• Mari Cassol Ferreira, Camila Piaia, Ana Carolina Cadore, Marinez Amabile Antoniolli, Geni Portela Gamborgi, and Patrícia Pereira de Oliveira.
• Universidade Comunitária da Região de Chapecó, Chapecó, SC, BR.
• Rev Assoc Med Bras (1992). 2015 Aug 1; 61 (4): 336340336-40.

Backgroundthe aim of the study was to evaluate the relationship between type 2 diabetes (T2DM), depression and depressive symptoms and their clinical impact on T2DM.Methodsthe authors evaluated 214 outpatients, 105 with diabetes (T2DM group) and 109 non-diabetics (control group), with ages ranging between 50 and 75 years (T2DM group 65.1 ± 5.6 years, control group 63.4 ± 5.8 years). Use of antidepressant treatment or score ≥ 16 on the Beck depression inventory (BDI) was considered depression. Complications of diabetes and total symptom score (TSS) for peripheral neuropathy were reported by patients.Resultsdiabetes group had a higher frequency of depression (35.2%) compared to controls (21.1%) (p=0,021), with 2.4 times increased risk of depression. The presence of depressive symptoms was also higher in T2DM group (mean BDI 9.5 ± 8.8 versus 6.9 ± 6.2; p=0.039). Symptoms of diabetic neuropathy were higher in depressed subjects. The metabolic control and presence of complications in T2DM group were not associated with depression.ConclusionT2DM led to an increased risk of depression, but this did not influence the metabolic control or the presence of other complications.

28 keywords...

hide…